• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IOTA附件模型分类为良性的无症状附件包块的保守治疗:一项葡萄牙前瞻性多中心研究

Conservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study.

作者信息

Brito Marta Espanhol, Borges André, Rodrigues Sofia, Ambrósio Paula, Condeço Raquel, Lacerda Abílio, Bernardo Maria José, Pinto Patrícia, Djokovic Dusan

机构信息

Maternidade Dr. Alfredo da Costa, Centro Hospitalar Universitário Lisboa Central (CHULC), 2890-495 Lisbon, Portugal.

Department of Obstetrics and Gynecology, Hospital de S. Francisco Xavier, Centro Hospitalar Lisboa Ocidental (CHLO), 1449-005 Lisbon, Portugal.

出版信息

Diagnostics (Basel). 2021 Oct 27;11(11):1992. doi: 10.3390/diagnostics11111992.

DOI:10.3390/diagnostics11111992
PMID:34829339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8625719/
Abstract

This prospective multicentric study aiming to determine the incidence of complications (malignant transformation, torsion or rupture) during conservative management of adnexal masses was performed in two Portuguese tertiary referral hospitals. It included ≥18-year-old, non-pregnant patients with asymptomatic adnexal masses (associated IOTA ADNEX risk of malignancy < 10%) sonographically diagnosed between January 2016 and December 2020. Conservative patient management consisted of serial clinical and ultrasound assessment up to 60 months of follow-up, spontaneous resolution of the formation or surgical excision (median follow-up: 17.8; range 9-48 months). From the 573 masses monitored (328 premenopausal and 245 postmenopausal adnexal masses), no complications were observed in 99.5%. The annual lesion growth rates and increases in morphological complexity were similar in the premenopausal and postmenopausal patients. Spontaneous resolution, evidenced in 16.4% of the patients, was more common in the premenopausal group ( < 0.05). Surgical intervention was performed in 18.4% of the cases; one borderline and one invasive FIGO IA stage cancer were diagnosed. There was an isolated case of ovary torsion (0.17%). These data support conservative management as a safe option for sonographically benign, stable and asymptomatic adnexal masses before and after menopause and highlight the need for expedite treatment of symptomatic or increased-morphological-complexity lesions.

摘要

这项前瞻性多中心研究在葡萄牙的两家三级转诊医院开展,旨在确定附件包块保守治疗期间并发症(恶变、扭转或破裂)的发生率。研究纳入了2016年1月至2020年12月期间经超声诊断为无症状附件包块(国际卵巢肿瘤分析(IOTA)附件恶性风险<10%)的18岁及以上非妊娠患者。患者的保守治疗包括进行长达60个月的系列临床和超声评估、肿物自行消退或手术切除(中位随访时间:17.8个月;范围9 - 48个月)。在监测的573个包块中(328个绝经前附件包块和245个绝经后附件包块),99.5%未观察到并发症。绝经前和绝经后患者的年肿物生长率及形态复杂性增加情况相似。16.4%的患者出现自行消退,在绝经前组更为常见(<0.05)。18.4%的病例进行了手术干预;诊断出1例交界性和1例FIGO IA期浸润性癌。有1例孤立的卵巢扭转病例(0.17%)。这些数据支持对于绝经前后超声检查显示为良性、稳定且无症状的附件包块,保守治疗是一种安全的选择,并强调了对有症状或形态复杂性增加的病变需加快治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/06aff0999b3a/diagnostics-11-01992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/81ee53edc6d0/diagnostics-11-01992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/7e8c5d7c3b6e/diagnostics-11-01992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/06aff0999b3a/diagnostics-11-01992-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/81ee53edc6d0/diagnostics-11-01992-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/7e8c5d7c3b6e/diagnostics-11-01992-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9359/8625719/06aff0999b3a/diagnostics-11-01992-g003.jpg

相似文献

1
Conservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study.IOTA附件模型分类为良性的无症状附件包块的保守治疗:一项葡萄牙前瞻性多中心研究
Diagnostics (Basel). 2021 Oct 27;11(11):1992. doi: 10.3390/diagnostics11111992.
2
Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.验证 ADNEX 和 IOTA 两步策略,并估计低危人群附件包块随访期间并发症的风险。
Ultrasound Obstet Gynecol. 2024 Sep;64(3):395-404. doi: 10.1002/uog.27642. Epub 2024 Aug 16.
3
Evaluating use of two-step International Ovarian Tumor Analysis strategy to classify adnexal masses identified in pregnancy: pilot study.评估两步法国际卵巢肿瘤分析策略在孕期附件包块分类中的应用:一项试点研究。
Ultrasound Obstet Gynecol. 2024 Dec;64(6):808-817. doi: 10.1002/uog.27707.
4
Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.对 IOTA 三步法特征描述和分类附件包块的前瞻性外部验证,以及使用简单规则风险的替代两步法的回顾性评估。
Ultrasound Obstet Gynecol. 2019 May;53(5):693-700. doi: 10.1002/uog.20163.
5
Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.IOTA ADNEX 模型在中国妇科肿瘤中心评估附件肿块的性能。
Ultrasound Obstet Gynecol. 2019 Dec;54(6):815-822. doi: 10.1002/uog.20363. Epub 2019 Nov 11.
6
Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study.附件包块中国际卵巢肿瘤分析ADNEX模型和卵巢附件报告与数据系统与最终组织学诊断的比较:一项回顾性研究
Obstet Gynecol Sci. 2024 Jan;67(1):86-93. doi: 10.5468/ogs.23061. Epub 2023 Oct 12.
7
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.保守治疗的卵巢肿瘤患者的并发症风险(IOTA5):一项多中心、前瞻性队列研究的 2 年中期分析。
Lancet Oncol. 2019 Mar;20(3):448-458. doi: 10.1016/S1470-2045(18)30837-4. Epub 2019 Feb 5.
8
Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses.超声评分在鉴别附件区良恶性肿块中的比较
Diagnostics (Basel). 2023 Mar 30;13(7):1307. doi: 10.3390/diagnostics13071307.
9
Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification.超声评分(主观评估、简单规则风险评估、ADNEX模型、O-RADS)在分类困难的附件包块中的应用
Diagnostics (Basel). 2023 Aug 28;13(17):2785. doi: 10.3390/diagnostics13172785.
10
Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.IOTA评分和ADNEX模型在绝经后女性卵巢恶性肿瘤筛查中的可靠性。
J Gynecol Obstet Hum Reprod. 2019 Feb;48(2):103-107. doi: 10.1016/j.jogoh.2018.04.012. Epub 2018 Apr 28.

本文引用的文献

1
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.英国卵巢癌筛查协作试验(UKCTOCS)长期随访后的卵巢癌人群筛查和死亡率:一项随机对照试验。
Lancet. 2021 Jun 5;397(10290):2182-2193. doi: 10.1016/S0140-6736(21)00731-5. Epub 2021 May 12.
2
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors.ESGO/ISUOG/IOTA/ESGE 关于卵巢肿瘤术前诊断的共识声明。
Ultrasound Obstet Gynecol. 2021 Jul;58(1):148-168. doi: 10.1002/uog.23635. Epub 2021 Jun 10.
3
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
经手术或保守治疗管理的卵巢癌患者的诊断模型验证:多中心队列研究。
BMJ. 2020 Jul 30;370:m2614. doi: 10.1136/bmj.m2614.
4
Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment.IOTA-ADNEX模型在鉴别附件包块特征方面的验证:与主观评估的比较
J Clin Med. 2020 Jun 26;9(6):2010. doi: 10.3390/jcm9062010.
5
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.O-RADS US 风险分层与管理系统:ACR 卵巢-附件报告和数据系统委员会的共识指南。
Radiology. 2020 Jan;294(1):168-185. doi: 10.1148/radiol.2019191150. Epub 2019 Nov 5.
6
Conservative management of adnexal masses.附件肿物的保守治疗。
Lancet Oncol. 2019 Mar;20(3):326-327. doi: 10.1016/S1470-2045(18)30939-2. Epub 2019 Feb 5.
7
Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.保守治疗的卵巢肿瘤患者的并发症风险(IOTA5):一项多中心、前瞻性队列研究的 2 年中期分析。
Lancet Oncol. 2019 Mar;20(3):448-458. doi: 10.1016/S1470-2045(18)30837-4. Epub 2019 Feb 5.
8
Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee.超声卵巢-附件报告术语词汇:ACR 卵巢-附件报告和数据系统委员会白皮书。
J Am Coll Radiol. 2018 Oct;15(10):1415-1429. doi: 10.1016/j.jacr.2018.07.004. Epub 2018 Aug 24.
9
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.卵巢癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Feb 13;319(6):595-606. doi: 10.1001/jama.2017.21421.
10
Long-term Results for Expectant Management of Ultrasonographically Diagnosed Benign Ovarian Teratomas.超声诊断良性卵巢畸胎瘤期待治疗的长期结果。
Obstet Gynecol. 2017 Dec;130(6):1244-1250. doi: 10.1097/AOG.0000000000002327.